The mo-Macs were predicted to deliver activation signals through the TNFR (TNF-TNFRSF1A), TGFBR (TGFB1-TGFBR2), and EGFR (EREG-EGFR) pathways to tumor cells. The gene discussed is TGFB1; the disease is neoplasm.